Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.31 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24390781 | 0.93 | ESR2 (0.38) | ESR2P2RY14 | |
| SCHEMBL21577530 | 0.90 | P2RY14 (0.33) | P2RY14 | |
| SCHEMBL22666394 | 0.89 | ESR2 (0.38) | ESR2P2RY14 | |
| SCHEMBL21577535 | 0.87 | HDAC2 (0.33) | P2RY14 | |
| SCHEMBL25919448 | 0.87 | CYP3A4 (0.34) | P2RY14 | |
| SCHEMBL21577521 | 0.86 | ESR2 (0.32) | ESR2P2RY14 | |
| SCHEMBL26383598 | 0.86 | EGLN1 (0.33) | P2RY14EGLN1EGLN3 | |
| SCHEMBL21577534 | 0.86 | ESR2 (0.33) | ESR2P2RY14 | |
| SCHEMBL21577536 | 0.86 | P2RY14 (0.31) | P2RY14 | |
| SCHEMBL21577529 | 0.86 | ESR2 (0.38) | ESR2P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230313043-A1 | OPTICAL COMPONENT | MERCK PATENT GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| US-20230313044-A1 | COMPOUND, COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND DEVICE | DIC CORPORATION (JP) | 2023-10-05 | — | — | US | disclosed |
| US-11639471-B2 | Compound, liquid crystal composition and high-frequency phase shifter | DIC CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| EP-4137552-A1 | LIQUID CRYSTAL COMPOSITION HAVING EXTREMELY LOW DIELECTRIC LOSS, AND HIGH-FREQUENCY COMPONENT COMPRISING SAME | Xi'an Modern Chemistry Research Institute (CN) | 2023-02-22 | — | — | EP | disclosed |
| WO-2022090109-A1 | AROMATIC ISOTHIOCYANATES | MERCK PATENT GMBH (DE) | 2022-05-05 | — | — | WO | disclosed |
| WO-2022090098-A1 | AROMATIC ISOTHIOCYANATES | MERCK PATENT GMBH (DE) | 2022-05-05 | — | — | WO | disclosed |
| US-11306251-B2 | Liquid-crystalline medium | MERCK PATENT GMBH (DE) | 2022-04-19 | — | — | US | disclosed |
| US-20220025264-A1 | COMPOUND, LIQUID-CRYSTAL COMPOSITION, AND RADIOFREQUENCY PHASE SHIFTER | DIC CORPORATION (JP) | 2022-01-27 | — | — | US | disclosed |
| WO-2022008474-A1 | OPTICAL COMPONENT | MERCK PATENT GMBH (DE) | 2022-01-13 | — | — | WO | disclosed |
| US-20210179943-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION AND HIGH-FREQUENCY PHASE SHIFTER | DIC CORPORATION (JP) | 2021-06-17 | — | — | US | disclosed |
| US-20190352564-A1 | LIQUID-CRYSTALLINE MEDIUM | MERCK PATENT GMBH (DE) | 2019-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230313044-A1 | COMPOUND, COMPOSITION, LIQUID CRYSTAL COMPOSITION, AND DEVICE | NLK, TTI2, LBR | ESR2 3690/4885P2RY14 1803/4885EGLN1 4570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.